About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Partnering Opportunities Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Innovation Engine Discuva Platform Scientific Literature & Publications Investors & Media Investor Center Media Center Press Releases Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Careers
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD)
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital
